Valmark Advisers Inc. grew its stake in UnitedHealth Group (NYSE:UNH) by 48.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,568 shares of the healthcare conglomerate’s stock after purchasing an additional 509 shares during the quarter. Valmark Advisers Inc.’s holdings in UnitedHealth Group were worth $346,000 as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. Exane Derivatives grew its position in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after buying an additional 460 shares during the last quarter. Trustcore Financial Services LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $133,000. Baystate Wealth Management LLC grew its position in shares of UnitedHealth Group by 64.9% during the 4th quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock valued at $186,000 after buying an additional 300 shares during the last quarter. NuWave Investment Management LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $168,000. Finally, Legacy Advisors LLC grew its position in shares of UnitedHealth Group by 546.0% during the 4th quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock valued at $176,000 after buying an additional 677 shares during the last quarter. Institutional investors and hedge funds own 86.79% of the company’s stock.
A number of brokerages recently weighed in on UNH. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price objective for the company in a research report on Tuesday. Cantor Fitzgerald reaffirmed a “buy” rating and set a $280.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 8th. Citigroup boosted their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Deutsche Bank boosted their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $244.06.
In other news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the sale, the insider now directly owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 77,015 shares of company stock valued at $17,879,199. Company insiders own 0.89% of the company’s stock.
Shares of NYSE:UNH opened at $223.96 on Friday. The company has a market capitalization of $221,391.59, a PE ratio of 22.24, a P/E/G ratio of 1.33 and a beta of 0.77. UnitedHealth Group has a twelve month low of $164.60 and a twelve month high of $250.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the business posted $2.11 EPS. equities analysts forecast that UnitedHealth Group will post 12.51 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
TRADEMARK VIOLATION WARNING: This piece of content was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/07/unitedhealth-group-unh-stake-raised-by-valmark-advisers-inc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.